Issue Date: February 29, 2016
Cerbios opens Swiss R&D center
The pharmaceutical services firm Cerbios-Pharma has opened an R&D center at its headquarters in Lugano, Switzerland, for the development of highly potent active pharmaceutical ingredients and monoclonal antibodies. The four-story, 1,120-m2 facility will house separate laboratories dedicated to biologics and small-molecule APIs manufactured to FDA’s current Good Manufacturing Practice quality standard.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society